News ID: 204556
Published: 0631 GMT November 19, 2017

Sea sponges ‘can save us from superbugs'

Sea sponges ‘can save us from superbugs'
express.co.uk

Scientists are harvesting bacteria-eating compounds from sea sponges that could be used to kill drug-resistant infections.

The molecules are 10 times stronger than existing antibiotics and can treat superbugs like Methicillin-resistant Staphylococcus aureus (MRSA), according to express.co.uk.

Scientists used mini submarines fitted with underwater cameras like those used on the blockbuster BBC David Attenborough Blue Planet II series to harvest them.

The Plymouth University researchers found the bacteria-killing compounds 1.25 miles below sea level.

Dr. Mathew Upton leads the team working with marine biologists to pinpoint sponges in the north Atlantic.

Samples are taken with remotely operated machine ‘hands’, brought to the surface and their bacteria-eating compounds identified with software that can pick out DNA sequences that are likely to produce new antibiotics.

In laboratory tests, some of the sponge compounds have been shown to rapidly destroy some of our most deadly superbugs, including hospital acquired infection MRSA.

It is hoped the compounds will be developed into new medicines and trialed within three to five years.

Upton said, “This is very exciting and could pave the way for a whole new class of antibiotics unaffected by current resistant problems.

“These compounds have been shown to be 10 times more potent than antibiotics produced at the moment.”

Traditional antibiotics only attack one part of the bacteria cell, making it easier for the bug to mutate and become antibiotic resistant.

The new agents are believed to be more effective as they attack the bacteria in at least two ways, making it harder for them to develop resistance.

Upton added, “The advance of antimicrobial resistance is relentless and many patients are now dying of untreatable infections.

“Antibiotics underpin all of modern medicine — not just to treat but to prevent infections such as post-surgery and cancer therapy or injury.

“If we lose antibiotics, things like this it will become too risky to perform for future generations.

“We believe the development of this new family of antibiotics will go some way to combatting the problem.”

Figures from the UK Sepsis Trust estimate at least 12,000 patients now die from drug resistant superbugs every year, though NHS England’s chief medical officer, Professor Dame Sally Davies, has claimed the figure is 5,000 are found.

The World Health Organization has warned antibiotic resistance is one of the biggest threats to global health, food security and development.

   
KeyWords
 
Comments
Comment
Name:
Email:
Comment:
Security Key:
Captcha refresh
Page Generated in 0/3166 sec